National Institutes of Health Panel Issues New Guidelines

A National Institutes of Health panel has released new guidelines on treating patients with COVID-19. Here are some of the highlights:

  • The panel does not recommend any drug for pre- or post-exposure prophylaxis outside of clinical trials.
  • It does not make a recommendation for specific antiviral or immunomodulatory treatments, as no drug has been proven to be safe and effective. The panel does provide rationale for use of certain therapies under investigation, as well as a summary of studies on these treatments.
  • It comes out against use of hydroxychloroquine plus azithromycin outside of clinical trials because of the toxicity risk, as well as against lopinavir/ritonavir or other HIV protease inhibitors because of negative clinical trial results and unfavorable pharmacodynamics. The panel also recommends against interferons and Janus kinase inhibitors.
  • The group recommends against use of systemic corticosteroids for mechanically ventilated adults with COVID-19 who don’t have acute respiratory distress syndrome (ARDS).
  • It prefers low-dose corticosteroids over no corticosteroids in patients with refractory shock.

The full text of the guidelines, with additional recommendations, is available at https://covid19treatmentguidelines.nih.gov/.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring.

Learn More about Spotlight On
Dr. Karam Mounzer

Dr. Mario Cruz

Dr. Mario CruzDr. Cruz is a board certified pediatrician who serves as the Medical Director for our Pediatrics and Adolescent Health Center. He has presented and/or published in the fields of community violence and domestic violence prevention, quality improvement, behavioral health, curriculum development and mentorship. In 2019 he received the Greater Philadelphia Social Innovation Award for Innovations in Healthcare.


Translate »